Paget-Schroetter Syndrome (PSS) and DVT

By SWA

Paget-Schroetter Syndrome, also known as effort thrombosis, is a form of deep vein thrombosis (DVT) that occurs in the upper extremities. This condition is typically associated with strenuous or repetitive activities that involve the arms, such as weightlifting, swimming, or pitching in baseball. PSS is considered a form of thoracic outlet syndrome (TOS), specifically venous thoracic outlet syndrome (VTOS).

Causes and Pathophysiology

  • Anatomy: PSS involves the subclavian vein, which passes through the thoracic outlet, a space bordered by the clavicle, first rib, and various muscles and ligaments.
  • Mechanism: Repetitive movements can cause compression of the subclavian vein, leading to endothelial damage, stenosis, and ultimately thrombosis.
  • Risk Factors: Athletes or individuals engaged in repetitive overhead arm activities are at higher risk. Anatomical variations and certain postures can also predispose individuals to PSS.

Symptoms

  • Swelling and pain in the affected arm.
  • Discoloration (bluish or purplish) of the arm.
  • Heaviness and tiredness in the arm.
  • Development of prominent collateral veins across the shoulder and upper chest.

Diagnosis

  • Doppler Ultrasound: Often the first imaging study used to assess blood flow and detect clots.
  • Venography: An invasive imaging technique where contrast dye is injected to visualize the veins.
  • Magnetic Resonance Imaging (MRI) and Computed Tomography (CT): May be used to assess the extent of vein compression and look for anatomical abnormalities.

Treatment

  • Anticoagulation: Immediate treatment to prevent further clot formation.
  • Thrombolysis: Clot-dissolving medications can be used in acute cases.
  • Surgery: Decompression surgery, such as first rib resection or scalenectomy, to relieve the compression of the subclavian vein.
  • Catheter-Directed Thrombolysis: Minimally invasive procedure to directly dissolve the clot.

Bilateral Venous Thoracic Outlet Syndrome (VTOS)

VTOS is a condition where the veins (typically the subclavian or axillary veins) are compressed as they pass through the thoracic outlet on both sides of the body. This is less common than unilateral VTOS but can occur due to similar mechanisms.

Causes and Pathophysiology

  • Anatomical Abnormalities: Bilateral compression can be due to congenital factors, anatomical variations, or acquired changes such as hypertrophy of muscles.
  • Repetitive Activities: Activities that involve repetitive overhead arm movements can exacerbate the condition.
  • Inflammation or Injury: Trauma or repetitive strain injuries can lead to inflammation and subsequent compression of the veins.

Symptoms

  • Similar to PSS, symptoms include swelling, pain, and discoloration of the arms.
  • Prominent collateral veins may develop in the chest and shoulders.
  • Symptoms are often bilateral, affecting both arms.

Diagnosis

  • Similar diagnostic methods to unilateral PSS, including Doppler ultrasound, venography, MRI, and CT.
  • Bilateral symptoms require careful assessment to rule out systemic causes or bilateral anatomical abnormalities.

Treatment

  • Anticoagulation and Thrombolysis: Initial treatment to manage thrombosis.
  • Surgical Decompression: Bilateral decompression surgery might be necessary.
  • Physical Therapy: To improve posture and reduce strain on the thoracic outlet.

Stenosis and Collateral Circulation

Significant stenosis in the right subclavian vein with the arm adducted indicates severe narrowing of the vein when the arm is in a specific position. This can be demonstrated through imaging studies that show a reduction in vein diameter and compromised blood flow. Multiple venous collaterals bypassing the stenosis suggest that the body has developed alternative pathways for blood to return to the heart, which is a compensatory mechanism to circumvent the blockage.

References

  1. Illig, K. A., & Doyle, A. J. (2010). "A comprehensive review of Paget-Schroetter syndrome." Journal of Vascular Surgery, 51(6), 1538-1547.
  2. Urschel, H. C., Jr., & Razzuk, M. A. (2008). "Paget-Schroetter syndrome: What is the best management?" Annals of Thoracic Surgery, 86(6), 2084-2090.
  3. Sanders, R. J., & Hammond, S. L. (2002). "Venous thoracic outlet syndrome." Hand Clinics, 18(1), 151-162.
  4. Kachlik, D., Pechacek, V., & Baca, V. (2013). "The clinical anatomy of the thoracic outlet syndrome: A comprehensive review." Clinical Anatomy, 26(5), 578-587.

These sources provide detailed information on the etiology, diagnosis, and management of Paget-Schroetter Syndrome and venous thoracic outlet syndrome, including the implications of significant stenosis and collateral circulation.

See fluoroscopic Chest X-Ray of this medical condition: https://x.com/i/status/1799944138949017909

Note: By reading my blog, you acknowledge that I do not provide medical diagnoses or treatments. The information provided is meant to answer frequently asked questions and is gathered from reputable scientific papers. 

 

Comments

Post a Comment

Popular posts from this blog

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By SWA
Image
Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially presenting as petechiae, diagnosed by a rheumatologist. However, following the second dose, symptoms rapidly escalated, resulting in intense burning pain and thinning of the skin. The skin on the legs and thighs became paper-thin and could tear with the slightest touch, with the affected area e...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By SWA
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By SWA
Image
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more